There are “myths” that surround the use of GLP-1 receptor agonists among patients, and it is a health care provider’s role to help their patients understand the benefits and adverse effects of these...
Obesity is associated with an increased risk for cardiovascular disease and other metabolic syndromes. When you treat patients with obesity, during which step of treatment do you suggest weight-loss...
Rates of reported child maltreatment have decreased during and following the COVID-19 pandemic, despite some studies reporting increase in abuse and/or neglect-related injuries among pediatric patients. How...
Researchers studied the use of a telehealth model to help clinicians care for patients with diabetes who may not have access to endocrinology care. Do you believe this is an adequate way to help this...
Individuals at high-risk for HIV infection often face barriers to testing, such as HIV-related stigma and difficulties with access to health services. In your opinion, which intervention strategies may have...
The proposed product standard by the FDA aims to reduce the number of youth and young adult smokers, while improving the health of those who do smoke. Do you believe this proposal will make an impact? ...
In 2020, a survey found that a majority of endocrinologists began providing care through telemedicine. More than 3 years later, is your practice still using telehealth in your practice? Let us know by...
Guidelines are in place so that the spread of tuberculosis (TB) infection is prevented and controlled in health care settings. Respond to our poll to let us know what your practice has done to limit the...
From patients not receiving recommended vaccinations to the increase in antibiotic resistance, there is a plethora of problems threatening public health. Which threat is the biggest one you face in your...
From patients not receiving recommended vaccinations to the increase in antibiotic resistance, there is a plethora of problems threatening public health. Which threat is the biggest one you face in your...
